1887

Journal of Medical Microbiology logo

Volume 66, Issue 8

Molecular diagnosis of rhino-orbito-cerebral mucormycosis from fresh tissue samples Free

Abstract

We aimed to evaluate a PCR-based technique for the diagnosis of mucormycosis and the identification of fungi from fresh tissue specimens in patients with rhino-orbito-cerebral-mucormycosis (ROCM).

Fifty cases of ROCM were included in the study. Conventional identification was performed using microscopy and culture. Molecular diagnosis was performed by amplifying the ribosomal DNA using pan-fungal ITS primers and semi-nested specific primers of the 18S region. The amplified products were sequenced to identify the agents. The utility of PCR–RFLP of the 18S region of rDNA was evaluated to identify the .

The ROCM cases were diagnosed by the demonstration of aseptate ribbon-like hyphae in biopsy specimens collected from the patients. Isolation was possible in 24 (48 %) samples. The ITS2 PCR confirmed mucormycosis in 27 cases (54 %; CI 59.4–68.2). By comparison, -specific PCR was able to amplify DNA and the sequence enabled the identification of speciesin all the patients. PCR-RFLP of the 18S region of rDNA could only identify the agent to genus level.

The molecular technique was able to identify species in 26 (42 %) cases that were negative by culture. specific semi-nested PCR targeting the 18S region is a better technique than ITS2 PCR for diagnosis. PCR-RFLP of the 18S region helps in identification to genus level.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): diabetes mellitus , molecular diagnosis , Mucorales , mucormycosis and panfungal primers
© 2017 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000560
2017-08-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/8/1124.html?itemId=/content/journal/jmm/10.1099/jmm.0.000560&mimeType=html&fmt=ahah

References

  1. Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European confederation of medical mycology (ECMM) working group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011; 17:1859–1867 [View Article][PubMed]
     [Google Scholar]
  2. Chakrabarti A, Dhaliwal M. Epidemiology of mucormycosis in India. Curr Fungal Infect Rep 2013; 7:287–292 [View Article]
     [Google Scholar]
  3. Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK et al. The rising trend of invasive Zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 2006; 44:335–342 [View Article][PubMed]
     [Google Scholar]
  4. Spellberg B, Edwards J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18:556–569 [View Article][PubMed]
     [Google Scholar]
  5. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA et al. Epidemiology and outcome of Zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41:634–653 [View Article][PubMed]
     [Google Scholar]
  6. Marr KA, Patterson T, Denning D, Aspergillosis DD. Aspergillosis. pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002; 16:875–894[PubMed] [CrossRef]
     [Google Scholar]
  7. Espinel-Ingroff A, Chakrabarti A, Chowdhary A, Cordoba S, Dannaoui E et al. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrob Agents Chemother 2015; 59:1745–1750 [View Article][PubMed]
     [Google Scholar]
  8. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51:45–52 [View Article][PubMed]
     [Google Scholar]
  9. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 2014; 20:5–26 [View Article][PubMed]
     [Google Scholar]
  10. Lass-Flörl C, Mayr A. Diagnosing invasive fungal diseases – limitations of microbiological diagnostic methods. Expert Opin Med Diagn 2009; 3:461–470 [View Article][PubMed]
     [Google Scholar]
  11. Schelenz S, Barnes RA, Barton RC, Cleverley JR, Lucas SB et al. British society for medical mycology best practice recommendations for the diagnosis of serious fungal diseases. British society for medical mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2015; 15:461–474 [CrossRef]
     [Google Scholar]
  12. Vaidya D, Shah P. Coinfection by Aspergillus and Zygomycetes species in a case of acute rhinosinusitis. Case Rep Otolaryngol 2011; 2011:382473 [View Article][PubMed]
     [Google Scholar]
  13. Shashir W, Rupali S, Sujata L, Preeti M. Concomitant Zygomycosis and Aspergillosis of the rhinocerebral region in a post renal transplant patient. Indian J Transpl 2014; 8:25–27 [View Article]
     [Google Scholar]
  14. Bialek R, Konrad F, Kern J, Aepinus C, Cecenas L et al. PCR based identification and discrimination of agents of mucormycosis and Aspergillosis in paraffin wax embedded tissue. J Clin Pathol 2005; 58:1180–1184 [View Article][PubMed]
     [Google Scholar]
  15. Hammond SP, Bialek R, Milner DA, Petschnigg EM, Baden LR et al. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol 2011; 49:2151–2153 [View Article][PubMed]
     [Google Scholar]
  16. Rickerts V, Mousset S, Lambrecht E, Tintelnot K, Schwerdtfeger R et al. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis 2007; 44:1078–1083 [View Article][PubMed]
     [Google Scholar]
  17. Ghatak S, Muthukumaran RB, Nachimuthu SK. A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. J Biomol Tech 2013; 24:224–231 [View Article][PubMed]
     [Google Scholar]
  18. Lau A, Chen S, Sorrell T, Carter D, Malik R et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol 2007; 45:380–385 [View Article][PubMed]
     [Google Scholar]
  19. Ochodo EA, Bossuyt PM. Reporting the accuracy of diagnostic tests: the STARD initiative 10 years on. Clin Chem 2013; 59:917–919 [View Article][PubMed]
     [Google Scholar]
  20. Chakrabarti A, Chatterjee SS, Das A, Panda N, Shivaprakash MR et al. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J 2009; 85:573–581 [View Article][PubMed]
     [Google Scholar]
  21. Chakrabarti A, das A, Sharma A, Panda N, Das S et al. Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect 2001; 42:261–266 [View Article][PubMed]
     [Google Scholar]
  22. Chakrabarti A, Ghosh A, Prasad GS, David JK, Gupta S et al. Apophysomyces elegans: an emerging Zygomycete in India. J Clin Microbiol 2003; 41:783–788 [View Article][PubMed]
     [Google Scholar]
  23. Raja HA, Miller AN, Pearce CJ, Oberlies NH. Fungal identification using molecular tools: a primer for the natural products research community. J Nat Prod 2017; 80:756–770 [View Article][PubMed]
     [Google Scholar]
  24. Vu D, Groenewald M, Szöke S, Cardinali G, Eberhardt U et al. DNA barcoding analysis of more than 9000 yeast isolates contributes to quantitative thresholds for yeast species and genera delimitation. Stud Mycol 2016; 85:91–105 [View Article][PubMed]
     [Google Scholar]
  25. Muñoz-Cadavid C, Rudd S, Zaki SR, Patel M, Moser SA et al. Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR. J Clin Microbiol 2010; 48:2147–2153 [View Article][PubMed]
     [Google Scholar]
  26. Dannaoui E, Schwarz P, Slany M, Loeffler J, Jorde AT et al. Molecular detection and identification of Zygomycetes species from paraffin-embedded tissues in a murine model of disseminated Zygomycosis: a collaborative European society of clinical microbiology and infectious diseases (ESCMID) fungal infection study group (EFISG) evaluation. J Clin Microbiol 2010; 48:2043–2046 [View Article][PubMed]
     [Google Scholar]
  27. Lass-Flörl C, Resch G, Nachbaur D, Mayr A, Gastl G et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis 2007; 45:e101e104 [View Article][PubMed]
     [Google Scholar]
  28. Badiee P, Arastefar A, Jafarian H. Comparison of histopathological analysis, culture and polymerase chain reaction assays to detect mucormycosis in biopsy and blood specimens. Iran J Microbiol 2013; 5:406–410[PubMed]
     [Google Scholar]
  29. Machouart M, Larché J, Burton K, Collomb J, Maurer P et al. Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism. J Clin Microbiol 2006; 44:805–810 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000560
Loading
Molecular diagnosis of rhino-orbito-cerebral mucormycosis from fresh tissue samples
J. Med. Microbiol. 66, 1124 (2017); https://doi.org/10.1099/jmm.0.000560
/content/journal/jmm/10.1099/jmm.0.000560
/content/journal/jmm/10.1099/jmm.0.000560
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error